Significant Ownership of Coastlands Capital LP

Large-stake snapshot 1 signal
Large-stake filing summary
  • Recent SEC Schedule 13D/G filings for Coastlands Capital LP focus on large-stake beneficial ownership disclosures and amendments.
  • Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
Manager Names, identifiers, and filing context for this profile. 2 identity fields
Manager signature
/s/ Mark Shamia - Chief Operating Officer of the General Partner, Coastlands Capital LLC
Manager location
San Francisco, CA

Significant Ownership of Coastlands Capital LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BOLT Bolt Biotherapeutics, Inc. Common Stock, par value $0.00001 per share 18% $1,521,815 412,416 Coastlands Capital LP 30 Oct 2026
ADIL Adial Pharmaceuticals, Inc. Common Stock, par value $0.001 per share 14% $1,112,500 +$331,242 373,322 +42% Coastlands Capital LP 24 Jun 2026
KTTA Pasithea Therapeutics Corp. Common Stock, par value $0.0001 per share 11% $2,339,371 +$878,565 3,835,035 +60% Coastlands Capital LP 09 Apr 2026
CAMP Camp4 Therapeutics Corp Common stock, par value $0.0001 per share 10% $21,452,710 4,886,722 Coastlands Capital LP 10 Sep 2025
NERV Minerva Neurosciences, Inc. Common Stock, par value $0.0001 per share 10% $18,571,536 4,563,031 Coastlands Capital LP 13 Feb 2026
XFOR X4 Pharmaceuticals, Inc. Common Stock, par value $0.001 per share 10% $7,773,911 +$37,418 2,491,638 +0.48% Coastlands Capital LP 03 Oct 2025
XLO Xilio Therapeutics, Inc. Common Stock, par value $0.0001 per share 10% $3,742,248 5,346,069 Coastlands Capital LP 04 Dec 2025
ELOX Eloxx Pharmaceuticals, Inc. Common Stock, par value $0.01 per share 10% 410,530 +54% Coastlands Capital LP 10 Jun 2026
IBIO iBio, Inc. Common Stock, par value $0.001 per share 9.7% $8,746,833 6,247,738 Coastlands Capital LP 07 Oct 2026
OKUR OnKure Therapeutics, Inc. Class A Common Stock, par value $0.0001 per share 6.7% $10,233,000 2,700,000 Coastlands Capital LP 01 Oct 2026
Frazier Life Sciences Acquisition Corp. II Class A Ordinary Shares, par value $0.0001 per share 6.4% 500,000 Coastlands Capital LP 15 Oct 2026
WHWK Whitehawk Therapeutics, Inc. Common stock 6% $5,074,587 2,819,215 Coastlands Capital LP 19 Aug 2025
KLRS Kalaris Therapeutics, Inc. Common Stock, par value $0.0001 per share 5.7% $3,916,158 1,355,119 Coastlands Capital LP 19 Oct 2026
PYXS Pyxis Oncology, Inc. Common Stock, par value $0.001 per share 5.4% $21,087,926 6,448,907 Coastlands Capital LP 01 Oct 2026
STRO Sutro Biopharma, Inc. Common Stock, par value $0.001 per share 5.1% $13,736,668 852,669 Coastlands Capital LP 05 Nov 2026
ELDN Eledon Pharmaceuticals, Inc. Common Stock, par value $0.001 per share 5% $6,733,682 -$1,410,519 3,937,826 -17% Coastlands Capital LP 31 Dec 2025
Azora Therapeutics, Inc. Common Stock, par value $0.001 per share 5% 655,975 Coastlands Capital LP 02 Nov 2026
NEUP Neuphoria Therapeutics Inc. Common Stock, par value $0.00001 per share 4.2% $992,007 +$471,255 228,594 +90% Coastlands Capital LP 23 Jul 2026

Schedules 13D/G Reported by Coastlands Capital LP:

Sym Target Class Ownership Change Current shares Change Value Reporting name Form Report period Filing date
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .